FDA Updates Modified Risk Tobacco Product Orders for Swedish Match USA

Regulations by 2FIRSTS.ai

Jul.04.2024

FDA Updates Modified Risk Tobacco Product Orders for Swedish Match USA

FDA reissues two applications related to Swedish Match's General Snus products, extending public comment period for further review.

According to a news update on the official website of the US Food and Drug Administration (FDA) on July 3, FDA has reissued two application documents related to the Modified Risk Tobacco Product (MRTP) order for Swedish Match USA, Inc.'s General Snus products. These reissued documents contain previously edited content and are now available for viewing on the Swedish Match MRTP application webpage.

In addition, the FDA has extended the public comment period for the Swedish Match Company's MRTP update application to allow the public more time to review the recently reissued application materials. The public can submit comments on the application on the regulations.gov webpage with the docket number FDA-2014-N-1051. The FDA will announce the deadline for the comment period after it is determined.

These application materials have been edited in accordance with applicable laws and regulations and can be found on the FDA's website. Before making a final decision on the MRTP application, the FDA will consider all available information, including public comments and recommendations from the Tobacco Products Scientific Advisory Committee (TPSAC).

References:

[1] Swedish Match USA, Inc.’s Renewal MRTP Applications for General Snus Products: Materials Reposted, Comment Deadline Extended

Also Read:

[1] US Supreme Court Overturns Precedent, Impacting E-Cigarette Industry and FDA

[2] Supreme Court to Review FDA E-Cigarette Products Decision

[3] FDA Tobacco Product Center Updates Tobacco Compliance Inspection Results Database

[4] BAT Submits Final PMTA for Age Restriction Devices for Vuse Pro ENDS Device

[5] Altria Group Submits PMTA for on! PLUS Nicotine Pouches

#North America #United States #Traditional tobacco #Regulation #FDA #Product

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Extends Ferrari Partnership to 2026, Bringing ZYN Nicotine Pouches to F1

Philip Morris International (PMI) has announced that it will extend its partnerships with Scuderia Ferrari HP and the Ferrari Challenge through the 2026 season and beyond, with its smoke-free nicotine pouch brand ZYN set to appear on Ferrari’s F1 livery for the first time from the 2025 Abu Dhabi Grand Prix. The company estimates that, as of June 30, 2025, more than 41 million adult consumers were using its smoke-free products worldwide.

Dec.04 by 2FIRSTS.ai

Russia’s Vape Market Squeezed by Excise Hikes and Criminal Marking Rules

According to Business FM, Russia’s vape and e-liquid supply has tightened since mid-Aug; by early Oct top liquids had largely disappeared and prices rose ~50% vs early summer. Shops cite a two-year excise hike to RUB 44/mL and, from Aug, criminal liability for unmarked goods (large-scale from RUB 100k), prompting withdrawals. Some chains report compliant substitutes. A bill would let regions ban vape sales.

Oct.30 by 2FIRSTS.ai

PMI’s Smoke-Free Playbook: What Jacek Olczak Really Told Wall Street

At the Morgan Stanley Global Consumer & Retail Conference on December 2, 2025, PMI CEO Jacek Olczak delivered a clear message: the company’s smoke-free shift is now its central strategy. From ZYN’s surge in the U.S. to IQOS’s global momentum and a changing regulatory tone, his remarks sounded less like an earnings update and more like a declaration of PMI’s smoke-free future.

PMI

Dec.03

iMiracle and VPR Reach Preliminary Settlement in ‘Elf’ Trademark Dispute, Potentially Ending Three-Year Legal Battle